Navigation Links
BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research

INDIANAPOLIS, Dec. 21, 2011 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive scientific management solutions, biomaterial storage and cold chain logistics for the bioscience industry, is pleased to announce the company has donated proceeds raised from its inaugural fundraising campaign to the Susan G. Komen for the Cure® Tissue Bank at the IU Simon Cancer Center. The $1,000 donation was presented to the Komen Tissue Bank on Monday, December 12th, 2011.

As part of the yearlong campaign, BioStorage Technologies donated one dollar or euro for anyone who left a business card, participated in booth activities or completed a contact form during industry tradeshows and conferences.  Funds to the Susan G. Komen for the Cure® Tissue Bank at IU Simon Cancer Center will be used to support research and new technologies in the areas of breast cancer awareness, education and advocacy.

"We're honored and flattered that BioStorage's first fundraising campaign was set up to benefit the Komen Tissue Bank," said Anna Maria Storniolo, M.D., co-director of the tissue bank and professor of clinical medicine at Indiana University School of Medicine. "The funds will help us to continue our important breast cancer research."

There are a number of biobanks globally that store tissue from women with breast cancer, but Komen Tissue Bank is the only known repository in the world for normal breast tissue and matched serum, plasma and DNA. These materials give researchers the resources needed to determine the differences between diseased and normal populations, which could lead to a better understanding of the disease.

Since becoming partners in 2009, BioStorage Technologies has stored a third of the tissue bank's breast tissue and blood samples at its Indianapolis-based biorepository.

"The Komen Tissue Bank is truly transforming breast cancer research by offering normal, high-quality, richly annotated tissue samples to scientists worldwide," said Greg Swanberg, Chief Executive Officer, BioStorage Technologies. "We're pleased that BioStorage Technologies is able to help successfully raise both awareness and funds to help support the tissue bank, as it will ultimately give researchers valuable and unprecedented research data. We look forward to continuing the partnership in 2012."

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering onsite or outsourced management of sample assets, BioStorage Technologies manages the complete life cycle of samples. With a team of global sample experts, state-of-the-art temperature-controlled storage facilities, and a real-time, web-based sample intelligence and tracking system, the company supports customers in maximizing opportunities, minimizing risk and reducing the cost of sample management. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit or call +1 (866) 697-2675 or +49-6155-898-1011.

About the Susan G. Komen for the Cure® Tissue Bank at the IU Simon Cancer Center

Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center is the only normal breast tissue bio-repository of its kind in the world.  As such, it is uniquely positioned to characterize the molecular and genetic basis of normal breast development and compare it to the different types of breast cancer. The bank was established expressly for the acquisition of normal tissues -- breast tissue, serum, and DNA -- from volunteer donors with no clinical evidence of breast disease and/or malignancy. The Komen Tissue Bank represents a unique resource available to --and used by -- an international group of investigators.

Press Contact:
Michael Clark
Miller Brooks, Inc.

SOURCE BioStorage Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
2. BioStorage Technologies Appoints New Member to Board of Directors
3. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo
4. BioStorage Technologies Expands Liquid Nitrogen Storage in Germany-based Biorepository Facility
5. BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference
6. BioStorage Technologies Showcases First-Ever Mobile Biorepository - Relofleet™ at Drug Information Association Annual Meeting
7. BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility
8. BioStorage Technologies Appoints New Director of Business Development for European Operations
9. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
10. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
11. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISS®
Post Your Comments:
(Date:11/25/2015)... , November 26, 2015 ... Global Biobanking Market 2016 - 2020 report analyzes ... maintaining integrity and quality in long-term samples, minimizing ... long-term cost-effectiveness. Automation minimizes manual errors such as ... technical efficiency. Further, it plays a vital role ...
(Date:11/25/2015)... , November 25, 2015 ... cat and human plaque and pave the way for more ... problems in cats     --> ... most commonly diagnosed health problems in cats, yet relatively little ... now. Two collaborative studies have been conducted by researchers from ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... Oregon , November 25, 2015 ... Market Research Report is a professional and in-depth ... industry.      (Logo: ) ... overview of the industry including definitions, classifications, applications ... is provided for the international markets including development ...
Breaking Biology Technology:
(Date:11/20/2015)... -- NXTD ) ("NXT-ID" or the "Company"), ... commerce market and creator of the Wocket® smart wallet, ... interviewed on The RedChip Money Report television ... Bloomberg Europe , Bloomberg Asia, Bloomberg Australia, and ... ) ("NXT-ID" or the "Company"), a biometric authentication company ...
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... -- Paris , qui s,est ... Paris , qui s,est tenu du 17 ... de l,innovation biométrique, a inventé le premier scanner couplé, ... la même surface de balayage. Jusqu,ici, deux scanners étaient ... empreintes digitales. Désormais, un seul scanner est en mesure ...
Breaking Biology News(10 mins):